Kazia: AGILE hurdle missed but significant value remains (ASX:KZA)

03 Aug, 2022 09:39 AM

Corporate Connect analyst Marc Sinatra has today released an updated research report for ASX-listed biotech company Kazia Therapeutics (ASX: KZA), now available for download via the KZA company page...read more